
Aurinia Pharmaceuticals Inc. – TSX:AUP.TO
Aurinia Pharmaceuticals stock price today
Aurinia Pharmaceuticals stock price yearly change
Aurinia Pharmaceuticals key metrics
Market Cap | N/A |
Enterprise value | 2.03B |
P/E | -11.44 |
EV/Sales | 35.35 |
EV/EBITDA | -13.40 |
Price/Sales | 37.31 |
Price/Book | 6.46 |
PEG ratio | -0.67 |
EPS | -1.23 |
Revenue | 57.59M |
EBITDA | -151.89M |
Income | -154.00M |
Revenue Q/Q | 22727.58% |
Revenue Y/Y | 18011.00% |
Profit margin | -267.41% |
Oper. margin | -244.89% |
Gross margin | 38.18% |
EBIT margin | -244.89% |
EBITDA margin | -263.74% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAurinia Pharmaceuticals stock price history
Aurinia Pharmaceuticals stock forecast
Aurinia Pharmaceuticals financial statements
Sep 2020 | 29K | -34.06M | -117462.07% |
---|---|---|---|
Dec 2020 | 50.03M | -22.55M | -45.08% |
Mar 2021 | 914K | -50.37M | -5511.93% |
Jun 2021 | 6.62M | -47.01M | -710.12% |
2020-03-05 | -0.18 | -0.78 |
---|---|---|
2020-05-14 | -0.24 | -0.15 |
2020-08-11 | -0.25 | -0.26 |
2020-11-10 | -0.22 | -0.28 |
Sep 2020 | 461750000 | 62.90M | 13.62% |
---|---|---|---|
Dec 2020 | 463661000 | 55.91M | 12.06% |
Mar 2021 | 417078000 | 46.85M | 11.23% |
Jun 2021 | 386268000 | 54.01M | 13.98% |
Sep 2020 | -30.28M | -142.63M | 189.25M |
---|---|---|---|
Dec 2020 | 5.45M | 16.89M | 1.24M |
Mar 2021 | -53.54M | -67.24M | 5.02M |
Jun 2021 | -37.97M | 1.67M | 1.27M |
Aurinia Pharmaceuticals alternative data
Aug 2023 | 294 |
---|---|
Sep 2023 | 294 |
Oct 2023 | 294 |
Nov 2023 | 294 |
Dec 2023 | 294 |
Jan 2024 | 294 |
Feb 2024 | 294 |
Mar 2024 | 294 |
Apr 2024 | 294 |
May 2024 | 294 |
Jun 2024 | 294 |
Jul 2024 | 294 |
Aurinia Pharmaceuticals other data
-
What's the price of Aurinia Pharmaceuticals stock today?
One share of Aurinia Pharmaceuticals stock can currently be purchased for approximately $16.76.
-
When is Aurinia Pharmaceuticals's next earnings date?
Unfortunately, Aurinia Pharmaceuticals's (AUP.TO) next earnings date is currently unknown.
-
Does Aurinia Pharmaceuticals pay dividends?
No, Aurinia Pharmaceuticals does not pay dividends.
-
What is Aurinia Pharmaceuticals's stock symbol?
Aurinia Pharmaceuticals Inc. is traded on the TSX under the ticker symbol "AUP.TO".
-
What is Aurinia Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Medical - Specialties industry.
-
How do i buy shares of Aurinia Pharmaceuticals?
Shares of Aurinia Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Aurinia Pharmaceuticals have?
As Jul 2024, Aurinia Pharmaceuticals employs 294 workers.
-
When Aurinia Pharmaceuticals went public?
Aurinia Pharmaceuticals Inc. is publicly traded company for more then 24 years since IPO on 19 Sep 2000.
-
What is Aurinia Pharmaceuticals's official website?
The official website for Aurinia Pharmaceuticals is auriniapharma.com.
-
Where are Aurinia Pharmaceuticals's headquarters?
Aurinia Pharmaceuticals is headquartered at 1203-4464 Markham St, Victoria, BRITISH COLUMBIA.
-
How can i contact Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals's mailing address is 1203-4464 Markham St, Victoria, BRITISH COLUMBIA and company can be reached via phone at +1 250 708 4272.
Aurinia Pharmaceuticals company profile:

Aurinia Pharmaceuticals Inc.
auriniapharma.comTSX
294
Medical - Specialties
Healthcare
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.
Victoria, BRITISH COLUMBIA V8Z 7X8
:
:
: